(Dr. M.M. Manson with Drs. A. Hudson and H. Ruchatz)
 

 

 

 

 

 

 

 

 

 

 
The following strategy has been adopted in order to investigate a potential chemopreventive agent at the cellular level. First the ability of the agent to induce growth arrest and apoptosis is investigated in a panel of cells derived from the target tissue, which should ideally include one or more cell lines which are as close as possible to normal tissue, in addition to tumour-derived lines. Fluorescence activated cell sorting (FACS analysis) is used to determine the precise effect on cell cycle and to quantitate the level of apoptosis. A significant difference in sensitivity between tumour and non-malignant lines is considered beneficial.
The ability of the agent to inhibit key signalling pathways involved in cell proliferation, oncogenic transformation and survival is then examined.
 
mechanisms of tumor suppression
Fig. legend:
Mechanisms of tumour suppression by interference with  cellular signalling.
Red arrows indicate points at which suspected cancer chemopreventive
agents are known to interfere with growth signals in preneoplastic cells.

 

Effects on key components of cell cycle control and apoptosis can be investigated as part of these signalling pathways or independently.
Effects on transcriptional regulation can also be examined.  In parallel, microarray analysis (screening some 6000 genes) is used to identify patterns of altered gene expression which relate to the observed effects on signalling or which represent novel targets.
The effects observed in cell culture in this part of the translational programme can then be investigated in vivo in suitable animal models (transgenic or otherwise) or in human tissue. The cell and molecular biology approach is essential to understanding the mechanism of action of the agent and also for predicting useful biomarkers to determine its efficacy in vivo.
 
 
  | The  GroupOncology in Leicester  | Why Chemoprevention  |  Mechanisms  Section
| Biomonitoring Section  |  Pharmacology Section  |  Achievements  | News |  References  |  Contacts